Page results
-
This leaflet has written by the administration team at the National Hospital for Neurology and Neurosurgery for outpatients.
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Lizzi Jordan, who received life-saving treatment at UCLH before going on to win a gold medal for cycling in the 2024 Paralympic Games, paid tribute to UCLH staff as she was made a Member of the British Empire (MBE).
-
Penile plication (Nesbit) procedure post-operative information
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
What to expect from your neuro-oncology Clinical Nurse Specialist (key worker) at the NHNN
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Information on the insertion of an inflatable penile prosthesis
File results
-
FOI/2021/0529 - Radiology department e-mail system for patients to reschedule appointments
-
FOI/2021/0531 - Neonatal care unit complaints over limited access due to Covid-19 restrictions
-
FOI/2021/0536 - PAT Testing
-
FOI/2021/0537 - Clinical waste information
-
FOI/2021/0538 - Treatment for triple-negative breast cancer
-
FOI/2021/0544 - Deaths for vaccinated and unvaccinated Covid-19 patients
-
FOI/2021/0547 - Stranded patients 13 days or more
-
FOI/2021/0550 - IT organisation chart and banding
-
FOI/2021/0551 - Analysing the treatment of neurology patients
-
FOI/2021/0553 - Clinical research organisations performing clinical trials